# Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion

> **NCT01557907** · PHASE1,PHASE2 · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 23 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** Subcutaneous delivery via Medtronic Quick-Set
- **DEVICE:** Intradermal delivery via the BD Research Catheter Set

## Key facts

- **NCT ID:** NCT01557907
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2012-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557907, "Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01557907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*